Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 9, 2015, Pages 988-1003

  Andrade, Pedro Z ^a,b   dos Santos, Francisco ^a,b   Cabral, Joaquim M S ^a   da Silva, Cláudia L ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b Advanced Therapeutics   (Portugal)

Author keywords

Bioreactors; ex vivo expansion; Haematopoietic stem progenitor cells; Oxygen tension; Stem cell bioengineering; Therapeutic applications; Umbilical cord blood

Indexed keywords

BIOREACTORS; BLOOD; CELL CULTURE; EXPANSION; OXYGEN; PRODUCT DESIGN; TECHNOLOGY TRANSFER;

BLOOD TRANSPLANTATION; CELL NUMBER; EX VIVO EXPANSION; HEMATOPOIETIC STEM/PROGENITOR CELLS; OXYGEN TENSION; STEM CELL BIOENGINEERING; STEM-CELL; THERAPEUTIC APPLICATION; UMBILICAL CORD BLOOD; UNIQUE FEATURES;

STEM CELLS;

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; FLT3 LIGAND; HYPOXIA INDUCIBLE FACTOR 1ALPHA; STEM CELL FACTOR; THROMBOPOIETIN; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; BIOENGINEERING; BIOREACTOR; BIOREACTOR DESIGN; BONE MARROW; CELL CULTURE EQUIPMENT; CELL FATE; CELL HOMING; CELL METABOLISM; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL SELECTION; CELL THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; FEEDER CELL; FLUIDIZED BED REACTOR; HEMATOPOIETIC BIOREACTOR; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OXYGEN TENSION; PACKED BED REACTOR; PERFUSION CHAMBER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ROLLER BOTTLE; ROTATING WALL VESSEL; STEM CELL BIOENGINEERING; STEM CELL CULTURE; STEM CELL EXPANSION; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; UMBILICAL CORD BLOOD; ADULT; CYTOLOGY; FETUS BLOOD; TISSUE ENGINEERING;

ADULT; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; TISSUE ENGINEERING;

EID: 84941599009     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1741     Document Type: Review

References (193)

1. Abranches E, Bekman E, Henrique D, et al. 2007; Expansion of mouse embryonic stem cells on microcarriers. Biotechnol Bioeng 96(6): 1211-1221.
2. Ahrlund-Richter L, De Luca M, Marshak DR, et al. 2009; Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 4(1): 20-26.
3. - cells in a long-term in vitro system. Exp Hematol 28(6): 690-699.
4. + cell enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion. J Cell Biochem 112(7): 1822-1831.
5. Andrade PZ, dos Santos F, Almeida-Porada G, et al. 2010; Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells. Mol Biosyst 6(7): 1207-1215.
6. Andrade PZ, Soure A, dos Santos F, et al. 2013; Ex vivo expansion of cord blood hematopoietic stem/progenitor cells under physiological oxygen tensions: clear-cut effects on cell proliferation, differentiation and metabolism. J Tissue Eng Regen Med.
7. 2-free atmosphere. Stem Cells Dev 20(4): 593-598.
8. Araki H, Mahmud N, Milhem M, et al. 2006; Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol 34(2): 140-149.
9. Audet J 2010; Adventures in time and space: nonlinearity and complexity of cytokine effects on stem cell fate decisions. Biotechnol Bioeng 106(2): 173-182.
10. Audet J, Miller CL, Eaves CJ, et al. 2002; Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotechnol Bioeng 80(4): 393-404.
11. Baumhueter S, Dybdal N, Kyle C, et al. 1994; Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for l-selectin. Blood 84(8): 2554-2565.
12. Benveniste P, Frelin C, Janmohamed S, et al. 2010; Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential. Cell Stem Cell 6(1): 48-58.
13. + marrow cells engraft lethally irradiated baboons. J Clin Invest 81(3): 951-955.
14. Bernard CJ, Connors D, Barber L, et al. 2004; Adjunct automation to the cellmate™ cell culture robot. J Assoc Lab Autom 9(4): 209-217.
15. Berson RE, Friederichs G. 2008; A self-feeding roller bottle for continuous cell culture. Biotechnol Prog 24(1): 154-157.
16. Bhatia M, Bonnet D, Murdoch B, et al. 1998; A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 4(9): 1038-1045.
17. Bilko NM, Votyakova IA, Vasylovska SV, et al. 2005; Characterization of the interactions between stromal and haematopoietic progenitor cells in expansion cell culture models. Cell Biol Int 29(1): 83-86.
18. Boitano AE, Wang J, Romeo R, et al. 2010; Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329(5997): 1345-1348.
19. Brandenberger R, Burger S, Campbell AM, et al. 2011; Integrating process and product development for the next generation of biotherapeutics. Bioproc Int 9(s1): 30-37.
20. Bravery CA, Carmen J, Fong T, et al. 2013; Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy 15(1): 9-19.e9.
21. + mobilized peripheral blood stem cells. Blood 91(1): 111-117.
22. Broxmeyer HE, Douglas GW, Hangoc G, et al. 1989; Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86(10): 3828-3832.
23. Brunstein CG, Barker JN, Weisdorf DJ, et al. 2009; Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transpl 43(12): 935-940.
24. Cabral JM. 2007; Cell partitioning in aqueous two-phase polymer systems. Adv Biochem Eng Biotechnol 106: 151-171.
25. Cabrita GJ, Ferreira BS, da Silva CL, et al. 2003; Hematopoietic stem cells: from the bone to the bioreactor. Trends Biotechnol 21(5): 233-240.
26. Cairo MS, Wagner JE. 1997; Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 90(12): 4665-4678.
27. Cashman JD, Clark-Lewis I, Eaves AC, et al. 1999; Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. Blood 94(11): 3722-3729.
28. CAT, committee for advanced therapies. 2011; Reflection paper on stem cell-based medicinal products. European Medicines Agency. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/02/WC500101692.pdf.
29. Chabannon C, Blache JL, Sielleur I, et al. 1999; Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: a feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide. Int J Oncol 15(3): 511-518.
30. Cheng X, Macvittie T, Meisenberg B, et al. 2007; Human brain endothelial cells (HUBEC) promote SCID repopulating cell expansion through direct contact. Growth Factors 25(3): 141-150.
31. Cho CH, Eliason JF, Matthew HW. 2008; Application of porous glycosaminoglycan-based scaffolds for expansion of human cord blood stem cells in perfusion culture. J Biomed Mater Res A 86(1): 98-107.
32. Chou S, Chu P, Hwang W, et al. 2010; Expansion of human cord blood hematopoietic stem cells for transplantation. Cell Stem Cell 7(4): 427-428.
33. Cipolleschi MG, Dello Sbarba P, Olivotto M. 1993; The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82(7): 2031-2037.
34. Cohen Y, Nagler A. 2004; Umbilical cord blood transplantation - how, when and for whom? Blood Rev 18(3): 167-179.
35. Collins PC, Miller WM, Papoutsakis ET. 1998a; Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol Bioeng 59(5): 534-543.
36. Collins PC, Nielsen LK, Patel SD, et al. 1998b; Characterization of hematopoietic cell expansion, oxygen uptake, and glycolysis in a controlled, stirred-tank bioreactor system. Biotechnol Prog 14(3): 466-472.
37. Csaszar E, Kirouac DC, Yu M, et al. 2012; Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell 10(2): 218-229.
38. da Silva CL, Goncalves R, Crapnell KB, et al. 2005; A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 33(7): 828-835.
39. + cells. J Tissue Eng Regen Med 4(2): 149-158.
40. da Silva CL, Gonçalves R, Porada CD, et al. 2009; Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics. J Cell Physiol 220(1): 102-111.
41. + cells after ex vivo expansion. Exp Hematol 29(12): 1465-1473.
42. Danet GH, Pan Y, Luongo JL, et al. 2003; Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 112(1): 126-135.
43. Dao MA, Creer MH, Nolta JA, et al. 2007; Biology of umbilical cord blood progenitors in bone marrow niches. Blood 110(1): 74-81.
44. Dao MA, Taylor N, Nolta JA. 1998; Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor-β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci USA 95(22): 13006-13011.
45. De Angeli S, Di Liddo R, Buoro S, et al. 2004; New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. Int J Mol Med 13(3): 363-371.
46. de Lima M, McMannis J, Gee A, et al. 2008; Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transpl 41(9): 771-778.
47. Delaney C, Heimfeld S, Brashem-Stein C, et al. 2010; Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 16(2): 232-236.
48. Diogo MM, da Silva CL, Cabral JMS. 2012; Separation technologies for stem cell bioprocessing. Biotechnol Bioeng 109(11): 2699-2709.
49. + hematopoietic cells from adults: gain and loss of CD34 antigen by undifferentiated cells are closely linked to proliferative status in culture. Stem Cells 22(4): 556-569.
50. - cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95(1): 102-110.
51. dos Santos F, Andrade PZ, Silva CL, Cabral JMS. 2013; Scaling-up ex vivo expansion of mesenchymal stem/stromal cells for cellular therapies. In Mesenchymal Stem Cell Therapy, Chase LG, Vemuri MC (eds). Humana Press: New York, NY; 1-14.
52. dos Santos F, Andrade PZ, Eibes G, et al. 2011; Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol 698: 189-198.
53. Douay L 2001; Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells. J Hematother Stem Cell Res 10(3): 341-346.
54. Drouet M, Mourcin F, Grenier N, et al. 2004; Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents non-human primates from myelosuppression: long-term follow-up of hematopoiesis. Blood 103(3): 878-885.
55. Du Z, Cai H, Ye Z, et al. 2012; Optimization of SCF feeding regimen for ex vivo expansion of cord blood hematopoietic stem cells. J Biotechnol 164(2): 211-219.
56. Duchez P, Chevaleyre J, Vlaski M, et al. 2012; Definitive set-up of clinical-scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantation. Cell Transpl 21(11): 2517-2521.
57. Dykstra B, Kent D, Bowie M, et al. 2007; Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1(2): 218-229.
58. Eibes G, dos Santos F, Andrade PZ, et al. 2010; Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146(4): 194-197.
59. Eliasson P, Jonsson JI. 2010; The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 222(1): 17-22.
60. Fernandes AM, Fernandes TG, Diogo MM, et al. 2007; Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. J Biotechnol 132(2): 227-236.
61. Fibbe WE, Nauta AJ, Roelofs H. 2007; Modulation of immune responses by mesenchymal stem cells. Ann NY Acad Sci 1106(Hematopoietic Stem Cells VI): 272-278.
62. Fortunel N, Hatzfeld J, Aoustin L, et al. 2000; Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood. Hematol J 1(2): 126-135.
63. Francesco F, Riccardo V, Francesca G, et al. 2010; The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases. Best practice and research. Clin Haematol 23(2): 237-244.
64. Freund D, Bauer N, Boxberger S, et al. 2006; Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev 15(6): 815-829.
65. Frias AM, Porada CD, Crapnell KB, et al. 2008; Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion. Exp Hematol 36(1): 61-68.
66. Gluckman E 2004; Ex vivo expansion of cord blood cells. Exp Hematol 32(5): 410-412.
67. Gluckman E 2009; History of cord blood transplantation. Bone Marrow Transpl 44(10): 621-626.
68. Gluckman E, Broxmeyer HA, Auerbach AD, et al. 1989; Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321(17): 1174-1178.
69. Gluckman E, Devergie A, Bourdeau-Esperou H, et al. 1990; Transplantation of umbilical cord blood in Fanconi's anemia. Nouv Rev Fr Hematol 32(6): 423-425.
70. Gossett DR, Weaver WM, Mach AJ, et al. 2010; Label-free cell separation and sorting in microfluidic systems. Anal Bioanal Chem 397(8): 3249-3267.
71. Guitart AV, Hammoud M, Dello Sbarba P, et al. 2010; Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen. Exp Hematol 38(10): 847-851.
72. Gunetti M, Ferrero I, Rustichelli D, et al. 2008; Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp Hematol 36(2): 235-243.
73. Hami L, Green C, Leshinsky N, et al. 2004; GMP production and testing of Xcellerated T cells for the treatment of patients with CLL. Cytotherapy 6(6): 554-562.
74. Hammond TG, Hammond JM. 2001; Optimized suspension culture: the rotating-wall vessel. Am J Physiol Renal Physiol 281(1): F12-25.
75. + cells improves the maintenance and proliferative capacity of hematopoietic stem cells. J Cell Physiol 227(6): 2750-2758.
76. + hematopoietic stem cells. Ann NY Acad Sci 996: 141-151.
77. Healy L, May G, Gale K, et al. 1995; The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 92(26): 12240-12244.
78. + cells. Stem Cells 24(1): 65-73.
79. Hofmeister CC, Zhang J, Knight KL, et al. 2007; Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transpl 39(1): 11-23.
80. Holyoake TL, Nicolini FE, Eaves CJ. 1999; Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27(9): 1418-1427.
81. Horner M, Miller WM, Ottino JM, et al. 1998; Transport in a grooved perfusion flat-bed bioreactor for cell therapy applications. Biotechnol Prog 14(5): 689-698.
82. Ingram M, Techy GB, Saroufeem R, et al. 1997; Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell Dev Biol Anim 33(6): 459-466.
83. Ivanovic Z 2009; Hypoxia or in situ normoxia: the stem cell paradigm. J Cell Physiol 219(2): 271-275.
84. 2 concentration (3%). Stem Cells 22(5): 716-724.
85. James D. 2011; Therapies of tomorrow require more than factories from the past. Bioproc Int 9(S1): 4-11.
86. Jaroscak J, Goltry K, Smith A, et al. 2003; Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101(12): 5061-5067.
87. Jauniaux E, Watson AL, Hempstock J, et al. 2000; Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157(6): 2111-2122.
88. Jelinek N, Schmidt S, Hilbert U, et al. 2002; Novel bioreactors for the ex vivo cultivation of hematopoietic cells. Eng Life Sci 2(1): 15-18.
89. Kawada H, Ando K, Tsuji T, et al. 1999; Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 27(5): 904-915.
90. Kedong S, Xiubo F, Tianqing L, et al. 2010; Simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood. J Mater Sci Mater Med 21(12): 3183-3193.
91. Kelly SS, Sola CB, de Lima M, et al. 2009; Ex vivo expansion of cord blood. Bone Marrow Transpl 44(10): 673-681.
92. Kim BS. 1998; Production of human hematopoietic progenitors in a clinical-scale stirred suspension bioreactor. Biotechnol Lett 20(6): 595-601.
93. Kim YJ, Broxmeyer HE. 2010; Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 79(2): 112-126.
94. Kirouac DC, Zandstra PW. 2008; The systematic production of cells for cell therapies. Cell Stem Cell 3(4): 369-381.
95. Ko HF, Bhatia R. 2012; Evaluation of single-use fluidized bed centrifuge system for mammalian cell harvesting. Biopharm Int 25(11): 34-40.
96. Koller MR, Bender JG, Miller WM, et al. 1993a; Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology (N Y) 11(3): 358-363.
97. Koller MR, Emerson SG, Palsson BO. 1993b; Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82(2): 378-384.
98. Koller MR, Manchel I, Newsom BS, et al. 1995; Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. J Hematother 4(3): 159-169.
99. - cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production. Exp Hematol 27(4): 734-741.
100. Kunitake R, Suzuki A, Ichihashi H, et al. 1997; Fully-automated roller bottle handling system for large scale culture of mammalian cells. J Biotechnol 52(3): 289-294.
101. Lackman F, Capewell V, Gagnon R, et al. 2001; Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol 185(3): 674-682.
102. Lazarus HM, Koc ON, Devine SM, et al. 2005; Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transpl 11(5): 389-398.
103. Le Blanc K, Frassoni F, Ball L, et al. 2008; Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371(9624): 1579-1586.
104. León A, Mayani H, Ramíres OT. 1998; Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions. Cytotechnology 28: 127-138.
105. Levee MG, Lee GM, Paek SH, et al. 1994; Microencapsulated human bone marrow cultures: a potential culture system for the clonal outgrowth of hematopoietic progenitor cells. Biotechnol Bioeng 43(8): 734-739.
106. Lewis ID, Almeida-Porada G, Du J, et al. 2001; Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 97(11): 3441-3449.
107. Liao Y, Geyer MB, Yang AJ, et al. 2011; Cord blood transplantation and stem cell regenerative potential. Exp Hematol 39(4): 393-412.
108. Liu Y, Liu T, Fan X, et al. 2006; Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel. J Biotechnol 124(3): 592-601.
109. Locatelli F 2009; Improving cord blood transplantation in children. Br J Haematol 147(2): 217-226.
110. Loureiro J, Andrade PZ, Cardoso S, et al. 2011; Magnetoresistive chip cytometer. Lab Chip 11(13): 2255-2261.
111. + cells: a omparison with human bone marrow-derived mesenchymal stem cells. Tissue Cell 45(1): 32-38.
112. Luni C, Feldman HC, Pozzobon M, et al. 2010; Microliter-bioreactor array with buoyancy-driven stirring for human hematopoietic stem cell culture. Biomicrofluidics 4(3).
113. Macmillan ML, Blazar BR, DeFor TE, et al. 2009; Transplantation of ex vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transpl 43(6): 447-454.
114. Madkaikar M, Ghosh K, Gupta M, et al. 2007; Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol 118(3): 153-159.
115. Madlambayan GJ, Rogers I, Kirouac DC, et al. 2005; Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. Exp Hematol 33(10): 1229-1239.
116. Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, Casper RF, Zandstra PW. 2006; Clinically relevant expansion of hematopoietic stem cells with conserved function in a single-use, closed-system bioprocess. Biol Blood Marrow Transplant 12(10): 1020-30.
117. Mantalaris A, Keng P, Bourne P, et al. 1998; Engineering a human bone marrow model: a case study on ex vivo erythropoiesis. Biotechnol Prog 14(1): 126-133.
118. Mason C, Hoare M. 2007; Regenerative medicine bioprocessing: building a conceptual framework based on early studies. Tissue Eng 13(2): 301-311.
119. Mayani H, Lansdorp PM. 1998; Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16(3): 153-165.
120. 2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12(10): 1007-1013.
121. McDowell CL, Papoutsakis ET. 1998; Decreasing extracellular pH increases CD13 receptor surface content and alters the metabolism of HL60 cells cultured in stirred tank bioreactors. Biotechnol Prog 14(4): 567-572.
122. McNiece I, Harrington J, Turney J, et al. 2004; Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. Cytotherapy 6(4): 311-317.
123. McNiece IK, Almeida-Porada G, Shpall EJ, et al. 2002; Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 30(6): 612-616.
124. Meissner P, Schroder B, Herfurth C, et al. 1999; Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells. Cytotechnology 30(1-3): 227-234.
125. Metcalf D 2008; Hematopoietic cytokines. Blood 111(2): 485-491.
126. + hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol 28(7): 858-870.
127. Mimeault M, Batra SK. 2006; Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 24(11): 2319-2345.
128. Montagna D, Locatelli F, Moretta A, et al. 2004; T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation. Blood 103(11): 4322-4329.
129. Moore KA, Lemischka IR. 2006; Stem cells and their niches. Science 311(5769): 1880-1885.
130. Morrison SJ, Uchida N, Weissman IL. 1995; The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 11: 35-71.
131. Mukhopadhyay A, Madhusudhan T, Kumar R. 2004; Hematopoietic stem cells: clinical requirements and developments in ex vivo culture. Adv Biochem Eng Biotechnol 86: 215-253.
132. Naughton BA, Naughton GK. 1989; Hematopoiesis on nylon mesh templates. Comparative long-term bone marrow culture and the influence of stromal support cells. Ann NY Acad Sci 554: 125-140.
133. Nielsen LK. 1999; Bioreactors for hematopoietic cell culture. Annu Rev Biomed Eng 1: 129-152.
134. Nishino T, Wang C, Mochizuki-Kashio M, et al. 2011; Ex vivo expansion of human hematopoietic stem cells by Garcinol, a potent inhibitor of histone acetyltransferase. PLoS One 6(9): e24298.
135. Nolta JA, Smogorzewska EM, Kohn DB. 1995; Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86(1): 101-110.
136. Novais JL, Titchener-Hooker NJ, Hoare M. 2001; Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals. Biotechnol Bioeng 75(2): 143-153.
137. Oostendorp RA, Robin C, Steinhoff C, et al. 2005; Long-term maintenance of hematopoietic stem cells does not require contact with embryo-derived stromal cells in cocultures. Stem Cells 23(6): 842-851.
138. Oritani K, Wu X, Medina K, et al. 1996; Antibody ligation of CD9 modifies production of myeloid cells in long-term cultures. Blood 87(6): 2252-2261.
139. Osawa M, Hanada K, Hamada H, et al. 1996; Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273(5272): 242-245.
140. Ozturk SS, Hu WS. 2006; Cell Culture Technology for Pharmaceutical and Cell-based Therapies, Press C (ed.). Taylor & Francis: Broken Sound Parkway NW, Boca Raton, FL.
141. Palsson BO, Paek SH, Schwartz RM, et al. 1993; Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnol (NY) 11(3): 368-372.
142. Pecora AL, Stiff P, Jennis A, et al. 2000; Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transpl 25(7): 797-799.
143. Piacibello W, Sanavio F, Garetto L, et al. 1997; Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89(8): 2644-2653.
144. Pierce L, Shabram P. 2004; Scalability of a disposable bioreactor from 25L-500L reun in perfusion mode with a CHO-based cell line: a tech review. BioProcess J 3(4): 51-56.
145. Plett PA, Frankovitz SM, Abonour R, et al. 2001; Proliferation of human hematopoietic bone marrow cells in simulated microgravity. In Vitro Cell Dev Biol Anim 37(2): 73-78.
146. Pollard PJ, Kranc KR. 2010; Hypoxia signaling in hematopoietic stem cells: a double-edged sword. Cell Stem Cell 7(3): 276-278.
147. Quesenberry PJ, Dooner GJ, Dooner MS. 2009; Problems in the promised land: status of adult marrow stem cell biology. Exp Hematol 37(7): 775-783.
148. Reems JA, Hall KM, Gebru LH, et al. 2008; Development of a novel assay to evaluate the functional potential of umbilical cord blood progenitors. Transfusion 48(4): 620-628.
149. Rich IN, Hall KM. 2005; Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Toxicol Sci 87(2): 427-441.
150. Riley BS, Li X. 2011; Quality by design and process analytical technology for sterile products - where are we now? AAPS Pharm Sci Tech 12(1): 114-118.
151. Robinson S, Niu T, de Lima M, et al. 2005; Ex vivo expansion of umbilical cord blood. Cytotherapy 7(3): 243-250.
152. Robinson SN, Ng J, Niu T, et al. 2006; Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transpl 37(4): 359-366.
153. Rodrigues CA, Fernandes TG, Diogo MM, et al. 2011a; Stem cell cultivation in bioreactors. Biotechnol Adv 29(6): 815-829.
154. Rodrigues CAV, Diogo MM, da Silva CL, et al. 2011b; Microcarrier expansion of mouse embryonic stem cell-derived neural stem cells in stirred bioreactors. Biotechnol Appl Biochem 58(4): 231-242.
155. Sandstrom CEB, Miller JWM, Papoutsakis ET. 1996; Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human mobilized peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma. Biotechnol Bioeng 50(5): 493-504.
156. Sardonini CA, Wu YJ. 1993; Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors. Biotechnol Prog 9(2): 131-137.
157. Sato T, Laver JH, Ogawa M. 1999; Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94(8): 2548-2554.
158. Scadden DT. 2006; The stem-cell niche as an entity of action. Nature 441(7097): 1075-1079.
159. Shih CC, Hu MCT, Hu J, et al. 1999; Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 94(5): 1623-1636.
160. Shpall EJ, Quinones R, Giller R, et al. 2002; Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transpl 8(7): 368-376.
161. Sideri A, Neokleous N, De La Grange PB, et al. 2011; An overview of the progress on double umbilical cord blood transplantation. Haematologica 96(8): 1213-1220.
162. Simsek T, Kocabas F, Zheng J, et al. 2010; The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7(3): 380-390.
163. Singh V 1999; Disposable bioreactor for cell culture using wave-induced agitation. Cytotechnology 30(1): 149-158.
164. Sjostedt S, Rooth G, Caligara F. 1960; The oxygen tension of the blood in the umbilical cord and the intervillous space. Arch Dis Childhood 35(184): 529-533.
165. Socolovsky M, Murrell M, Purpura KA, Liu Y, Pop R, Porpiglia E, Levchenko A. 2007; Negative autoregulation by FAS mediates robust fetal erythropoiesis. PLoS Biol 5(10): e252.
166. Stem-cell research: the state of the art. 2004; Stem Cells-Emerging Markets and Growth Opportunities. Frost & Sullivan: New York, NY, USA.
167. Steiner D, Gelovani J, Savoldo B, et al. 2009; Noninvasive bioluminescent imaging demonstrates long-term multilineage engraftment of ex vivo-expanded CD34-selected umbilical cord blood cells. Stem Cells 27(8): 1932-1940.
168. Sullivan M, Galea P, Latif S. 2006; What is the appropriate oxygen tension for in vitro culture? Mol Hum Reprod 12(11): 653.
169. Sullivan MJ. 2008; Banking on cord blood stem cells. Nat Rev Cancer 8(7): 555-563.
170. Takubo K, Goda N, Yamada W, et al. 2010; Regulation of the HIF-1α level is essential for hematopoietic stem cells. Cell Stem Cell 7(3): 391-402.
171. + cells an enhanced ex vivo expansion potential. Exp Hematol 22(13): 1264-1272.
172. + hematopoietic progenitor cells. Cytotherapy 14(6): 679-685.
173. Uchida N, Tsukamoto A, He D, et al. 1998; High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest 101(5): 961-966.
174. Verfaillie CM. 1992; Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79(11): 2821-2826.
175. Vose JM, Armitage JO. 1995; Clinical applications of hematopoietic growth factors. J Clin Oncol 13(4): 1023-1035.
176. Wagner W, Wein F, Roderburg C, et al. 2007; Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp Hematol 35(2): 314-325.
177. Walenda T, Bokermann G, Ventura Ferreira MNS, et al. 2011; Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp Hematol 39(6): 617-628.
178. Wang JC, Doedens M, Dick JE. 1997; Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89(11): 3919-3924.
179. Wang TY, Brennan JK, Wu JH. 1995; Multilineal hematopoiesis in a three-dimensional murine long-term bone marrow culture. Exp Hematol 23(1): 26-32.
180. Wang W, Horner DN, Chen WL, et al. 2008; Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects. Biotechnol Bioeng 99(5): 1261-1272.
181. Wang XN, Sviland L, Ademokun AJ, et al. 1998; Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model. Transplantation 66(7): 903-909.
182. Warburg O 1956; On the origin of cancer cells. Science 123(3191): 309-314.
183. Weissman IL, Shizuru JA. 2008; The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112(9): 3543-3553.
184. Williams DA. 1993; Ex vivo expansion of hematopoietic stem and progenitor cells - robbing Peter to pay Paul? Blood 81(12): 3169-3172.
185. Xiong F, Chen Z, Liu H, et al. 2002; Ex vivo expansion of human umbilical cord blood hematopoietic progenitor cells in a novel three-dimensional culture system. Biotechnol Lett 24: 1421-1426.
186. Yang S, Cai H, Jin H, et al. 2008; Hematopoietic reconstitution of CD34+ cells grown in static and stirred culture systems in NOD/SCID mice. Biotechnol Lett 30(1): 61-65.
187. Yao CL, Feng YH, Lin XZ, et al. 2006; Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133+ cells. Stem Cells Dev 15(1): 70-78.
188. Yin T, Li L. 2006; The stem cell niches in bone. J Clin Invest 116(5): 1195-1201.
189. Zandstra PW, Eaves CJ, Piret JM. 1994; Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. Biotechnology (NY) 12(9): 909-914.
190. + cells. Exp Hematol 26(4): 353-360.
191. Zanjani ED, Almeida-Porada G, Livingston AG, et al. 2003; Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp Hematol 31(5): 406-412.
192. Zhang CC, Kaba M, Iizuka S, et al. 2008; Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111(7): 3415-3423.
193. + cells with human mesenchymal stem cells. Tissue Eng 12(8): 2161-2170.